MILLENNIUM MANAGEMENT LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 80 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,209,683
-92.4%
189,529
-81.7%
0.00%
-91.3%
Q2 2023$94,307,722
+247180.2%
1,035,211
+79.0%
0.05%
+109.1%
Q1 2023$38,138
+3657.4%
578,201
+2844.6%
0.02%
+2100.0%
Q4 2022$1,015
-100.0%
19,636
-94.2%
0.00%
-92.3%
Q3 2022$23,076,000
+200.2%
337,869
+98.7%
0.01%
+160.0%
Q2 2022$7,687,000
+87.9%
170,000
+111.2%
0.01%
+66.7%
Q1 2022$4,090,000
-83.1%
80,505
-84.3%
0.00%
-75.0%
Q4 2021$24,207,000
+55.8%
512,002
+8.6%
0.01%
+33.3%
Q3 2021$15,536,000
+1516.6%
471,382
+3001.2%
0.01%
+800.0%
Q2 2021$961,000
-91.3%
15,200
-94.1%
0.00%
-87.5%
Q1 2021$11,095,000
-19.8%
258,571
+7.0%
0.01%
-20.0%
Q4 2020$13,826,000
-54.9%
241,714
-76.2%
0.01%
-73.7%
Q3 2020$30,674,000
-12.7%
1,016,703
-5.4%
0.04%
-20.8%
Q2 2020$35,118,000
-3.4%
1,075,250
-20.8%
0.05%
-41.5%
Q1 2020$36,370,000
+29.6%
1,357,586
+48.1%
0.08%
+134.3%
Q4 2019$28,060,000
-61.3%
916,406
-69.6%
0.04%
-69.3%
Q3 2019$72,541,000
+40.1%
3,011,261
+47.3%
0.11%
+46.2%
Q2 2019$51,793,000
+37.9%
2,043,924
+6.1%
0.08%
+39.3%
Q1 2019$37,568,000
+140.9%
1,926,566
+62.9%
0.06%
+133.3%
Q4 2018$15,596,000
-20.8%
1,182,385
+6.8%
0.02%0.0%
Q3 2018$19,684,000
+0.1%
1,107,109
+23.9%
0.02%
-7.7%
Q2 2018$19,656,000893,4600.03%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
venBio Partners LLC 1,526,122$29,759,00024.10%
Cormorant Asset Management, LP 3,600,000$70,200,0004.74%
SECTORAL ASSET MANAGEMENT INC 1,727,829$33,693,0004.05%
Hillhouse Capital Management 2,098,581$40,922,0001.71%
HHLR ADVISORS, LTD. 2,579,708$50,304,0001.40%
CLOUGH CAPITAL PARTNERS L P 589,734$11,500,0001.01%
Vivo Capital, LLC 383,538$7,479,0000.75%
Opaleye Management Inc. 115,000$2,243,0000.62%
Virtus ETF Advisers LLC 14,338$280,0000.60%
Eversept Partners, LP 104,349$2,034,8060.59%
View complete list of APELLIS PHARMACEUTICALS INC shareholders